title: Effect of hepatitis B virus infection on apoptosis of a human choriocarcinoma cell line in vitro.
abstract: OBJECTIVE
  To investigate the effect and mechanism of hepatitis B virus (HBV) infection on the human choriocarcinoma cell line, JEG-3, in relation to apoptosis and intrauterine infection.
  
  
  METHODS
  HBV-DNA serum was used to infect the choriocarcinoma cell line, JEG-3, in vitro. Real-time fluorescence quantitative PCR (RT-PCR) was then employed to detect intracellular replication of HBV DNA. Cells were also stained with Annexin-V and propidium iodide (PI) to identify the stages of apoptosis following infection. In addition, reverse transcription PCR was used to detect intracellular HBx mRNA levels, and Western blotting and immunohistochemistry were used to detect changes in the intracellular expression of HBxAg and phosphatidylinositol kinase 3 (PI3K). Flow cytometry was also used to detect the intracellular levels of phosphorylated AKT (pAKT).
  
  
  RESULTS
  After JEG-3 cells were infected with HBV in vitro, HBV DNA was detected. The percentage of cells in early and late stage apoptosis also decreased significantly. Expression of HBx mRNA and HBxAg were detected, and intracellular levels of PI3K and pAKT were observed to significantly increase.
  
  
  CONCLUSIONS
  HBV infected JEG-3 cells in vitro, resulting in an inhibition of early and late stage apoptosis. In addition, the HBxAg/PI3K/pAKT pathway is a possible mechanism mediating this inhibition of apoptosis, and the infection of the placenta by HBV.
authors.affiliation: Department of Gynecology and Obstetrics, The First Affiliated Hospital of Medical College of Xi'an Jiaotong University, Xi'an, China. baigq@126.com
authors.forename: Guiqin
authors.initials: G
authors.lastname: Bai
authors.forename: Fengping
authors.initials: F
authors.lastname: Fu
authors.forename: Yao
authors.initials: Y
authors.lastname: Tang
authors.forename: Yueling
authors.initials: Y
authors.lastname: Wang
mesh_terms: D017209:Apoptosis; D045744:Cell Line, Tumor; D002822:Choriocarcinoma; D004279:DNA, Viral / Q000032:analysis; D005434:Flow Cytometry; D006509:Hepatitis B / Q000635:transmission*; D006515:Hepatitis B virus / Q000502:physiology*; D006801:Humans; D007150:Immunohistochemistry; D018445:Infectious Disease Transmission, Vertical; D019869:Phosphatidylinositol 3-Kinases / Q000032:analysis; D051057:Proto-Oncogene Proteins c-akt / Q000032:analysis; D012333:RNA, Messenger / Q000032:analysis; D020133:Reverse Transcriptase Polymerase Chain Reaction; D015534:Trans-Activators / Q000032:analysis; D014327:Trophoblasts / Q000821:virology*; D054334:Viral Regulatory and Accessory Proteins
chemical_list: D004279:DNA, Viral; D019869:Phosphatidylinositol 3-Kinases; D051057:Proto-Oncogene Proteins c-akt; D012333:RNA, Messenger; D015534:Trans-Activators; D054334:Viral Regulatory and Accessory Proteins; C057628:hepatitis B virus X protein